Since c-Myc is a known driver of progression of clonal PCs in MGUS to MM, it is possible that the differences in the tryptophan-kynurenine metabolic pathway are a manifestation of one of many consequences of c-Myc activation. Here, MYC is linked to Miyoshi myopathy.